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one of these vessels was positive for Aβ at the site of rup-
ture. Moreover, the density of Aβ positive cortical vessels 
was lower (1.0 per mm2) within a range of 315 µm sur-
rounding the microhemorrhage, compared to control areas 
(2.0 per mm2; p < 0.05). These findings question the widely 
held assumption that the deposition of Aβ in the walls of 
cortical vessels directly causes microhemorrhages.
Keywords Amyloid β · Microbleeds · Small vessel 
disease · MRI
Introduction
Cerebral amyloid angiopathy (CAA) is a common small 
vessel pathology in the aging human brain. CAA is found 
in ~30 to 80% of older individuals on autopsy, and has 
increasingly been recognized as an important contribu-
tor to antemortem cognitive decline and dementia [1, 4]. 
On pathology, CAA is characterized by the deposition of 
amyloid β (Aβ) in the walls of cerebral leptomeningeal and 
cortical vessels. Severe CAA is associated with vasculo-
pathic changes, microinfarcts, and microhemorrhages [8, 
15, 20, 24]. The latter are considered the hallmark lesions 
of CAA, especially on MRI. The presence of multiple 
lobar cerebral ‘microbleeds’ (the MRI signature of old 
microhemorrhages) as detected on T2*-weighted in vivo 
MRI is strongly associated with CAA on pathology [17]. 
Due to the strong association between microhemorrhages 
and CAA, it is a widely held assumption that the deposi-
tion of Aβ in cortical vessels directly causes these vessels 
to rupture by making them fragile [24]. Accordingly, a 
longitudinal MRI study in CAA patients showed that new 
micro- and macrobleeds occurred preferentially at loca-
tions with increased levels of Aβ deposition as measured on 
Abstract Microhemorrhages are strongly associated with 
advanced cerebral amyloid angiopathy (CAA). Although 
it has been frequently proposed that the deposition of Aβ 
in the walls of cortical vessels directly causes microhem-
orrhages, this has not been studied in great detail, mainly 
because the ruptured vessels are often missed on routine 
histopathologic examination. Here, we examined histo-
pathological data from studies targeting microhemorrhages 
with high-resolution ex vivo 7 T MRI in nine cases with 
moderate-to-severe CAA, and assessed the presence of 
Aβ in the walls of involved vessels. We also assessed the 
density of Aβ positive cortical vessels in areas surround-
ing microhemorrhages compared to control areas. In seven 
out of 19 microhemorrhages, the presumed involved vessel 
could be identified on the histopathological section. Only 
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a previous PiB-PET MRI scan [9]. However, at the neuro-
pathological level, a recent autopsy study did not support 
a direct topographical relation between microhemorrhages 
and CAA, after examining histological sections from dif-
ferent brain areas in 113 consecutive autopsy cases [12]. 
Despite this lack of topographical relation between micro-
hemorrhages and CAA at the microscopic level, it remains 
unclear if the individual vessels that ruptured and gave rise 
to those microhemorrhages contained vascular Aβ deposi-
tions or not. It has proved to be challenging to assess this, 
because the ruptured vessels often escape detection on rou-
tine pathologic examination.
Here, we used high-resolution ex vivo 7 tesla (T) MRI 
to ensure successful retrieval of microhemorrhages to study 
the presence of Aβ in the walls of vessels involved in those 
microhemorrhages. Moreover, we assessed the density of 
Aβ positive cortical vessels in areas surrounding microhe-
morrhages, and compared them to control areas and areas 




For this study, we analyzed histopathological data of 
autopsy cases with CAA previously acquired in the con-
text of two post-mortem MRI studies ([22]; referred to 
as the Boston data set and [21]; referred to as the Utrecht 
data set). Both studies were aimed at assessing the histo-
pathology of MRI-observed microbleeds. Inclusion crite-
ria for the Boston data set were presence >10 microbleeds 
on in vivo clinical MRI and histopathologically confirmed 
CAA on autopsy (n = 5 cases). Inclusion criteria for the 
Utrecht data set was severe CAA on autopsy (n = 5 cases). 
In both studies, formalin-fixed brain slabs from these cases 
were subjected to ex vivo 7 T MRI and samples were 
taken from representative microbleeds for histopathologi-
cal examination. For the purpose of this study, we selected 
the samples from cases with moderate-to-severe CAA on 
pathology only. One case (from the Boston data set) had 
mild CAA and was, therefore, not considered for the cur-
rent analysis. Hence, the samples from nine cases were 
entered into the analysis.
Ex vivo MRI and sampling
The ex vivo 7 T MRI protocol that was used in both stud-
ies included high-resolution T2 and T2*-weighted MRI 
scans. Representative cerebral microbleeds, identified 
by one rater using established rating criteria [25], were 
sampled for histopathological examination. The sampled 
tissue blocks were processed and embedded in paraffin. 
Next, 6-μm-thick serial sections were cut on a microtome, 
guided by MRI. At the level of the microhemorrhage, the 
first section was stained for hematoxylin and eosin (H&E). 
Adjacent sections were stained with a monoclonal antibody 
against Aβ (NAB228 for the Boston data set [13]; anti-Aβ 
(clone 6F/3D) purchased from DAKO for the Utrecht data 
set). All retrieved lesions were examined by a neuropathol-
ogist (MPF for the Boston data set, AJMR for the Utrecht 
data set).
Analysis of the histopathology data
For this study, we selected the histopathological sections 
containing old or recent microhemorrhages, as confirmed 
by the neuropathologist on microscopic examination of 
those sections. As previously described, old microhemor-
rhages were defined as focal hemosiderin deposits with 
or without hematoidin, whereas recent microhemorrhages 
were defined as extravasated intact or (partly) lysed eryth-
rocytes [21, 22].
Qualitative assessment of involved vessels
First, we determined if the presumed involved vessel was 
present on the H&E-stained section, defined as a vessel 
with evidence of rupture and/or surrounded by erythrocytes 
or hemosiderin and/or hematoidin deposits (i.e., the micro-
hemorrhage itself). If the involved vessel could be identi-
fied, we assessed the presence of Aβ in the wall of that ves-
sel on the adjacent Aβ-stained section.
Density of Aβ positive cortical vessels
Second, we assessed the density of Aβ positive cortical ves-
sels in the tissue surrounding the microhemorrhages, see 
Supplemental Figure 1. A microhemorrhage was excluded 
for this analysis if another microhemorrhage was present 
within 3 mm on the same section, to avoid any potential 
influence. Where possible, for each microhemorrhage, two 
or three control areas were taken from intact cortical areas 
harboring CAA but lacking microhemorrhages on the same 
section (>5 mm away from the microhemorrhage). Pho-
tographs were obtained from both the microhemorrhage 
area, and control areas on the same microscope, through a 
1× objective. Additional images with a 2× objective were 
taken to assist rating. Next, on the obtained images, the 
areas of interest were defined by manually outlining the 
cortical ribbon (omitting the underlying white matter and 
leptomeningeal vessels). Microhemorrhages were masked 
by manually placing a circular or oval shape covering the 
microhemorrhage. On the control areas, an identical (in 
terms of size and shape) ‘placebo’ mask was placed over 
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the cortex in the center of the obtained photograph, thereby 
avoiding bias for CAA severity in the surrounding areas. 
One week later, all images were assessed for Aβ positive 
vessels by one observer (SJvV) blinded to microhemor-
rhage presence (i.e., the observer did not know whether the 
circular or oval shape masked a microhemorrhage or not), 
by placing markers in the center of Aβ positive cortical 
vessels in an in-house developed interface incorporated in 
MeVisLab (MeVis Medical Solutions AG, Bremen, Ger-
many). Because the leptomeningeal vessels were not pre-
served on all sections, these vessels were not analyzed. The 
area surrounding the masks was divided into six concentric 
shells each of 315 μm in width (or 50 pixels). The number 
of Aβ positive cortical vessels per shell was generated by 
the software. The density of Aβ positive cortical vessels/
mm2 in each shell was calculated by dividing the number 
of Aβ positive cortical vessels per shell by the area of that 
particular shell. Differences between density in microhem-
orrhage areas and control areas on the same section were 
assessed by paired samples t test per shell, in Graphpad 
Prism (version 7.00).
Results
In total, 19 ex vivo MRI-targeted microhemorrhages were 
available for analysis (nine from the Boston data set and ten 
from the Utrecht data set). On histopathology, 12 proved to 
be old, and seven acute microhemorrhages. In seven (three 
acute and four old) out of 19 microhemorrhages, the pre-
sumed involved vessel could be identified on the adjacent 
Aβ-stained section. In six out of these seven vessels, the 
walls were negative for Aβ (Fig. 1). Interestingly, in one 
autopsy case, four additional vessels with fibrinoid necro-
sis (confirmed by phosphotungstic acid/hematoxylin stain) 
were observed, for which adjacent Aβ-stained sections 
were available. None of these vessels were positive for Aβ 
(Fig. 2).
Next, we hypothesized based on the initial qualitative 
results that microhemorrhages might occur preferentially in 
CAA-sparse microareas. Hence, we assessed the density of 
Aβ positive cortical vessels in shells close to microhemor-
rhages compared to shells further away. Two microhemor-
rhages were excluded, because they were located in close 
Fig. 1  Vascular Aβ was absent in the walls of six out of seven vessels 
that were involved in microhemorrhages in cerebral amyloid angi-
opathy. A recent microhemorrhage was identified on an H&E-stained 
section, characterized by the presence of intact erythrocytes (arrows) 
in the parenchyma, surrounding a penetrating cortical vessel (a, inset 
shows enlargement of boxed area; adapted from [22] with permis-
sion). The adjacent Aβ-stained section revealed that the involved ves-
sel was negative for Aβ (broken arrows), whereas neighboring vessels 
did contain Aβ (arrows) (b, inset shows enlargement of boxed area, 
broken arrows indicate absence of Aβ in the wall of this vessel). In 
another case, an old microhemorrhage was identified on an H&E-
stained section, characterized by the focal deposition of hemosiderin 
(blue deposits in inset) in the parenchyma, surrounding a cortical ves-
sel (broken arrow in inset) (c, inset shows Perl’s Prussian blue stain-
ing of the area outlined in the box for enhanced detection of hemo-
siderin). The adjacent Aβ-stained section revealed that the involved 
vessel was negative for Aβ (broken arrows in inset), as well as vessels 
in close proximity to the microhemorrhage (broken arrows), whereas 
vessels further away did contain Aβ (arrows) (d, inset shows enlarge-
ment of boxed area). All scale bars indicate 250 µm
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proximity (<3 mm) to another microhemorrhage, leaving 
17 microhemorrhages for analysis. Per microhemorrhage 
area, at least one or two control areas were chosen from the 
same histopathological section. If ≥2 control areas were 
taken on one section, the average densities (per shell) for 
those control areas were entered into the paired samples 
analysis. Only the shell directly adjacent (<315 μm) to a 
microhemorrhage had a lower density of Aβ positive cor-
tical vessels compared to its control shell (t(16) = 2.152; 
p < 0.05) (Fig. 3). For shells further away from the micro-
hemorrhage, we found no difference in density from con-
trols. We repeated the analysis after standardizing the den-
sity for each area, to see if this changed the results. First, 
we calculated the average density of all six shells. Next, we 
divided the density of Aβ positive cortical vessels for each 
shell, by the average density of all six shells. This approach 
did not change the results.
Finally, we assessed whether the observed lower density 
of Aβ positive cortical vessels could be explained by local 
tissue damage as a result of the microhemorrhage. Hence, 
we repeated the analysis around microinfarcts (n = 8), 
another frequently observed CAA-related microvascular 
lesion causing local tissue damage (Supplemental Fig. 2). 
We found no difference between microinfarct areas and 
control areas (Fig. 3). This suggests that the observed lower 
density of Aβ positive cortical vessels close to a microhe-
morrhage is not likely due to tissue damage caused by the 
lesion in that area.
Discussion
In this exploratory observational histopathological study, 
we found that only one out of seven preserved vessels that 
were involved in microhemorrhages contained Aβ. More-
over, we observed a lower density of Aβ positive cortical 
vessels in the microenvironment closest to the microhem-
orrhages, suggesting that microhemorrhage formation may 
not be a direct consequence of more severe CAA locally, 
and indeed may occur preferentially in areas of relatively 
low CAA. These findings question a frequently proposed 
mechanism that microhemorrhage formation in CAA is 
a direct consequence of Aβ deposition in the walls of the 
responsible vessels.
There is no doubt that hemorrhages are manifestations 
strongly associated with CAA, as supported by a large 
body of the literature (e.g., [11, 23, 24]). Nevertheless, it 
remains unclear what exact mechanisms drive a particular 
vessel segment in a brain with advanced CAA to bleed. 
At the larger spatial scale resolved by MRI and amyloid-
PET (>2 mm2), higher levels of amyloid are spatially 
associated with MRI-observed microbleeds [3, 9], but 
only a few studies have directly investigated this relation 
at the single vessel level. A recent neuropathology study 
that assessed the relation between microhemorrhages and 
CAA in sections obtained at autopsy for routine neuro-
pathologic examination found no significant association 
between the presence of CAA and microhemorrhages in 
Fig. 2  Vascular Aβ was absent in the walls of vessels with fibrinoid 
necrosis in cerebral amyloid angiopathy. Two severely dilated vessels 
with fibrinoid necrosis (arrows, also confirmed by phosphotungstic 
acid/hematoxylin stain, not shown) were identified on H&E (a, b) 
(b was adapted from [21] with permission). The adjacent Aβ-stained 
section revealed that these vessels were negative for Aβ (broken 
arrows), whereas neighboring vessels did contain Aβ (c). Boxed areas 
in c represent areas contained in a and b respectively
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any brain region that was examined [12]. Although the 
authors did not investigate the vessels directly involved 
in those microhemorrhages, they noted that microhemor-
rhages were mainly observed at the cortical-white matter 
junction, whereas CAA was restricted to superficial and 
short penetrating cortical vessels.
Capturing a microhemorrhage, and in particular, the 
involved vessel of a microhemorrhage on routine patho-
logical examination of the autopsied brain in CAA is dif-
ficult. Microhemorrhages are not frequently captured in 
routine sections, and therefore often missed upon neu-
ropathological examination. Moreover, the majority of 
microhemorrhages that are captured in a section are more 
likely to be old and (partly) degraded. For those reasons, 
there are only a few examples where the presence of rup-
tured vessels on a section in the context of CAA is men-
tioned. Probably, one of the first reports was by Vonsattel 
and colleagues [24]. In this paper, 136 brains without hem-
orrhage and 17 brains with CAA with hemorrhage were 
examined. Interestingly, the authors report findings from 
serial sections taken from one case with CAA and multiple 
microhemorrhages. These serial sections disclosed a direct 
relationship between fibrinoid necrosis and the site of rup-
ture of the vessel wall, with or without erythrocyte extrava-
sation. The authors noted that these vessels were congo-
philic, but it remains unclear if the vascular Aβ deposits 
were observed at the site of rupture or more remotely. More 
recently, a postmortem MRI study targeting MRI-observed 
microbleeds for histopathological analysis in CAA, men-
tioned that for several corresponding histopathologically 
confirmed hemorrhages, it was possible to determine which 
vessel ruptured. Aβ staining in those vessels demonstrated 
the presence of Aβ deposits in the walls of involved ves-
sels [19]. Others, however, did not observe Aβ at sites of 
rupture [7, 16]. One study analyzed vessels in 3D after 
serial sectioning and found that at the site of rupture, the 
vessels were dilated and exhibited fibrinoid necrosis in the 
absence of vascular Aβ [10, 16]. Interestingly, the vessels 
did contain Aβ further upstream and downstream in the 
same vessel.
To increase retrieval of ruptured vessels, we made use of 
high-resolution ex vivo MRI to target lesions for detailed 
histopathological analysis. Moreover, we performed serial 
sectioning to capture the site of rupture on a single thin sec-
tion [5]. Even using this targeted approach, 12 out of 19 
ruptured vessels were still unavailable for detailed histo-
pathologic examination, either because they were lost in 
the process of sectioning or because they had deteriorated 
over time, which is more likely in the case of old micro-
hemorrhages. Hence, it cannot be ruled out that these ves-
sels did contain Aβ before they ruptured. However, the fact 
that only one out of seven available involved vessels was 
positive for Aβ suggests that it is unlikely that Aβ always 
directly causes vessels to rupture and calls for different 
additional explanatory mechanisms by which CAA indi-
rectly results in microhemorrhage formation.
One possible explanation for our observations is that 
the extravasation of erythrocytes pushes away the Aβ 
deposits from the vessel wall, hence rendering the site of 
rupture amyloid-negative on subsequent histopathologi-
cal examination. Another possible explanation could be 
that early immune reactions, such as the infiltration of 
macrophages, result in clearing of Aβ in the area. How-
ever, the absence of Aβ in the walls of recent microhem-
orrhages as well as yet unruptured vessels with fibrinoid 
Fig. 3  Density (vessels/mm2) of Aβ positive cortical vessels was 
lower in the shell directly adjacent to a microhemorrhage, compared 
to shells further away. The first shell adjacent to a microhemorrhage 
contained a lower density of Aβ positive cortical vessels compared 
to control areas (upper graph). This effect was not observed in shells 
further away from the lesion. Moreover, the first shell adjacent to a 
microinfarct did not contain a lower density of Aβ positive cortical 
vessels compared to control areas (lower graph). This suggests that 
the observed lower density of Aβ positive cortical vessels adjacent 
to a microhemorrhage was not caused by tissue damage in that shell. 
*p < 0.05 (paired samples t test). Error bars represent SEM. The 
graphs depict the first three shells. The width of one shell was set at 
50 pixels, which equals 315 μm. Microhemorrhages: n = 17; total 
number of CTRL areas: n = 34; microinfarcts: n = 8
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necrosis, a pathologic change that is strongly associated 
with microhemorrhage formation [24], does not sup-
port these explanations. Moreover, the observation that 
the density of Aβ positive cortical vessels was lower 
directly adjacent to a microhemorrhage also supports that 
the lesion was not caused by more severe CAA locally. 
Finally, the fact that we did not observe a similar lower 
density of Aβ positive cortical vessels close to microin-
farcts suggests that this was unlikely due to tissue damage 
in the adjacent area of the microvascular lesion. A more 
likely explanation for our findings would be that vascular 
Aβ deposition does not cause vessels to rupture directly 
or locally, but that it may have an indirect effect on the 
integrity of the microvascular network. A known conse-
quence of CAA is impaired autoregulation (e.g., dys-
functional regulation of cerebral blood flow), which may 
lead to weak spots in the microvasculature in the case of 
alterations in systemic blood pressure [2, 6]. It is conceiv-
able that such blood pressure changes increase the risk 
of rupture at weak vessel segments without vascular Aβ 
deposits. If this is true, one would expect to find vascular 
Aβ deposits in vessels upstream or downstream of the site 
of rupture. This would also explain previous observations 
of Aβ positive vessels associated with hemorrhages [19, 
24] and spatial associations between amyloid-PET imag-
ing and MRI-observed microbleeds [3, 9].
This study has several limitations. First, we cannot rule 
out that there may have been some bias in selecting the 
control areas, unconsciously in CAA-rich regions. Second, 
the presence of Aβ in the walls of vessels was assessed on 
a single thin section stained for Aβ. Hence, no information 
was available on the segments of the same vessels above 
and below those sections. Future studies are warranted to 
verify our observations in larger volumes of tissue, by ana-
lyzing the cortical microvascular network in 3D. This can 
for instance be achieved by optically clearing samples, as 
recently demonstrated for formalin-fixed human tissue 
[18], as well as for a whole mouse brain [14]. Interestingly, 
the latter study reported small foci of hemosiderin deposits 
in close proximity to vessels with CAA by means of 3D 
reconstructions of individual vessels in a mouse model of 
Alzheimer’s disease [14]. Third, because this study con-
sisted of a relatively small data set, there is a possibility of 
a false-positive finding. However, the shell-analysis was 
performed with a pre-specified hypothesis and provided 
independent confirmation of the initial independent quali-
tative finding of absent CAA at bleeding sites. Finally, it 
could be possible that the microhemorrhages observed in 
our study were the result of other (age-related) pathological 
processes that often coexist with CAA, such as hyperten-
sive arteriopathy. Other factors that might have influenced 
some of our observations are prolonged formalin exposure 
as well as secondary effects of therapeutic interventions 
prior to death. Moreover, extending our findings in the con-
text of other (hereditary) small vessel diseases with asso-
ciated microhemorrhages would be an interesting topic for 
further research.
Conclusions
Our findings question a widely held assumption that the 
deposition of Aβ in the walls of cortical vessels directly 
causes microhemorrhages. Further studies are needed to 
validate this observation in larger data sets and to deter-
mine the exact mechanisms by which vascular Aβ leads to 
hemorrhage formation in CAA.
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